Patent ID: 8765810

Claim:
A method of treating rheumatoid arthritis, psoriasis, ankylosing spondylitis, Crohn's disease, or ulcerative colitis comprising administering to a patient in need of such treatment an effective amount of a pharmaceutical composition comprising a compound having a structure of Formula (III), or a pharmaceutically acceptable salt thereof: wherein R 10 , R 11 , and R 12 are each independently hydrogen, alkyl, hydroxyl, alkoxy, NR 13 R 14 , halogen, nitro, cyano, borono, aryl, aryloxy, benzyl, —(CH 2 ) n COOR 15 , —O(CH 2 ) n COOR 16 , —OC(O)R 17 , —CR 18 ═NOH, —CR 19 R 20 NHOH, —SO 3 H, —SO 2 R 21 , —SO 2 NHR 22 , —O(CH 2 ) m OR 23 , —C(OH)═NOH, —C(O)NR 24 OH, CHR 25 N(COR 26 )OH, or C(O)R 27 ; R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 , R 24 , R 25 , and R 26 are each independently hydrogen, alkyl, or aryl, and R 27 is alkyl or aryl; and n and m are independently 0, 1, 2, 3, 4, 5, or 6; and pharmaceutically acceptable excipient.